Description
An active metabolite of gemcitabine; formed by deamination of gemcitabine by cytidine deaminase in the liver; cytotoxic to HepG2 and A549 cancer cells (IC50s = 3.13 and 3.92 µM, respectively); enhances radiation-induced cell death of ECV304 and NCI H292 cells from 10-100 µM
Formal name: 2′-deoxy-2′,2′-difluoro-uridine
Synonyms: dFdU
Molecular weight: 264.2
CAS: 114248-23-6
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Nucleotides/Nucleosides||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Cancer|Cell Death||Research Area|Cancer|DNA Damage and Repair||Research Area|Epigenetics, Transcription, & Translation|Writers|DNA/RNA Methylation||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|HIV & AIDS||Research Area|Toxicology|Drug Metabolism|Drug Metabolites